New Treatment Gives Hope For Pulmonary Fibrosis Patients
Thursday, May 22, 2008 - 15:14
in Health & Medicine
Patients with idiopathic pulmonary fibrosis may have a new treatment option, according to researchers in Japan. In a Phase III, double-blind, placebo-controlled clinical trial, the investigators discovered that a daily dose of pirfenidone could slow the progression of IPF, reducing the loss of lung capacity.
Read the whole article on Science Daily
More from Science Daily
Related
- New treatment gives hope for pulmonary fibrosis patientsTue, 20 May 2008, 8:49:14 EDT
- The risk factors of idiopathic pulmonary fibrosis in HCV patientsThu, 23 Oct 2008, 9:56:53 EDT
- Large clinical trial finds pirfenidone may help lung function in IPF patientsSun, 17 May 2009, 13:42:52 EDT
- Hope for patients with COPDFri, 15 Aug 2008, 8:15:18 EDT
- Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patientsTue, 7 Jul 2009, 5:28:37 EDT